Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deep Learning Model for Predicting Immunotherapy Response in Advanced Non-Small Cell Lung Cancer.
Rakaee M, Tafavvoghi M, Ricciuti B, Alessi JV, Cortellini A, Citarella F, Nibid L, Perrone G, Adib E, Fulgenzi CAM, Murilo Hidalgo Filho C, Di Federico A, Jabar F, Hashemi S, Houda I, Richardsen E, Rasmussen Busund LT, Donnem T, Bahce I, Pinato DJ, Helland Å, Sholl LM, Awad MM, Kwiatkowski DJ. Rakaee M, et al. Among authors: bahce i. JAMA Oncol. 2024 Dec 26. doi: 10.1001/jamaoncol.2024.5356. Online ahead of print. JAMA Oncol. 2024. PMID: 39724105
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer.
Houda I, Bahce I, Dickhoff C, Kroese TE, Kroeze SGC, Mariolo AV, Tagliamento M, Moliner L, Brandão M, Pretzenbacher Y, Edwards J, Opitz I, Brunelli A, Guckenberger M, van Schil PE, Popat S, Blum T, Faivre-Finn C, de Ruysscher D, Remon J, Berghmans T, Dingemans AC, Besse B, Hendriks LEL. Houda I, et al. Among authors: bahce i. Lung Cancer. 2024 Dec 15;199:108061. doi: 10.1016/j.lungcan.2024.108061. Online ahead of print. Lung Cancer. 2024. PMID: 39705827 Free article.
Evaluation of Spliceosome Protein SmD2 as a Potential Target for Cancer Therapy.
Li J, Li P, Brachtlova T, van der Meulen-Muileman IH, Dekker H, Kumar VS, Fransen M, Bahce I, Felley-Bosco E, van Beusechem VW. Li J, et al. Among authors: bahce i. Int J Mol Sci. 2024 Dec 6;25(23):13131. doi: 10.3390/ijms252313131. Int J Mol Sci. 2024. PMID: 39684842 Free PMC article.
Sex and Common Germline Variants Affect the Toxicity Profile and Pharmacokinetics of Alectinib: A Nationwide Cohort Study in Patients With ALK-Positive NSCLC.
Heersche N, Lanser DAC, Muntinghe-Wagenaar MB, Mohmaed Ali MI, Ulas EB, Trooster TMA, de Jonge E, Oomen-de Hoop E, Paats MS, Bahce I, Croes S, Hendriks LEL, van der Wekken AJ, Dingemans AC, Huitema ADR, van Schaik RHN, Mathijssen RHJ, Veerman GDM. Heersche N, et al. Among authors: bahce i. J Thorac Oncol. 2024 Nov 29:S1556-0864(24)02488-2. doi: 10.1016/j.jtho.2024.11.025. Online ahead of print. J Thorac Oncol. 2024. PMID: 39617342 Free article.
Stereologic consequences of iatrogenic collapse: The morphology of adenocarcinoma in situ overlaps with invasive patterns. Proposal for a necessary modified classification of pulmonary adenocarcinomas.
Filipello F, Blaauwgeers H, Lissenberg-Witte B, Schonau A, Doglioni C, Arrigoni G, Radonic T, Bahce I, Smit A, Dickhoff C, Nuccio A, Bulotta A, Minami Y, Noguchi M, Ambrosi F, Thunnissen E. Filipello F, et al. Among authors: bahce i. Lung Cancer. 2024 Nov;197:107987. doi: 10.1016/j.lungcan.2024.107987. Epub 2024 Oct 5. Lung Cancer. 2024. PMID: 39388963 Free article.
Pharmacokinetic analysis and simplified uptake measures for tumour lesion [18F]F-AraG PET imaging in patients with non-small cell lung cancer.
Wijngaarden JE, Slebe M, Pouw JEE, Oprea-Lager DE, Schuit RC, Dickhoff C, Levi J, Windhorst AD, Oordt CWMHV, Thiele A, Bahce I, Boellaard R, Yaqub M. Wijngaarden JE, et al. Among authors: bahce i. Eur J Nucl Med Mol Imaging. 2024 Oct 8. doi: 10.1007/s00259-024-06931-3. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39377810
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study.
Bahce I, Dickhoff C, Schneiders FL, Veltman J, Heineman DJ, Hashemi SMS, Vrijmoet A, Houda I, Ulas EB, Bakker J, van de Ven P, Bouwhuis N, Meijboom LJ, Oprea-Lager DE, van Maldegem F, Fransen MF, de Gruijl TD, Radonic T, Senan S. Bahce I, et al. J Immunother Cancer. 2024 Sep 30;12(9):e009799. doi: 10.1136/jitc-2024-009799. J Immunother Cancer. 2024. PMID: 39349061 Free PMC article. Clinical Trial.
90 results